Yüklüyor......

Toxicity profile of epidermal growth factor receptor tyrosine kinase inhibitors in patients with epidermal growth factor receptor gene mutation-positive lung cancer

Recent progress in the research on the molecular biology of lung cancer revealed that the clinical response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is associated with the presence of activating EGFR mutations. Three EGFR-TKIs, namely afatinib, erlotinib and gefit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Clin Oncol
Asıl Yazarlar: Takeda, Masayuki, Nakagawa, Kazuhiko
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2017
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5244907/
https://ncbi.nlm.nih.gov/pubmed/28123721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.1099
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!